The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Sox10 and S100 in the Diagnosis of Soft-tissue Neoplasms
Abstract
Despite a well-characterized lack of specificity, pathologists routinely employ S100 in the diagnosis of neural crest-derived tumors. Recent studies have shown that Sox10 is a reliable marker of neural crest differentiation that is consistently expressed in schwannian and melanocytic tumors. We sought to validate these results in a larger series of soft tissue neoplasms of both neural crest and non-neural crest origin, and to further characterize the sensitivity and specificity of Sox10 for use in clinical diagnosis. We evaluated Sox10 and S100 mRNA levels in 122 cases of peripheral nerve sheath tumors and synovial sarcoma and used immunohistochemistry for Sox10 and S100 protein expression in 1012 tissue specimens. This study includes 174 tissue microarray cases previously reported by Nonaka and colleagues, which include cases of melanoma, dermatofibrosarcoma protuberans, neurofibroma, synovial sarcoma, clear-cell sarcoma, malignant peripheral nerve sheath tumor (MPNST), perineurioma, and schwannoma. Synovial sarcomas expressed significantly higher levels of S100B than Sox10 (P=7.9×10), and no significant Sox10 mRNA expression was identified in synovial sarcoma (n=40), whereas 18/40 cases showed comparatively increased levels of S100 mRNA. The majority of schwannomas (n=26) and neurofibromas (n=28) showed relatively an increased expression of both Sox10 and S100 mRNA. MPNSTs (n=28) showed variable levels of Sox10 and S100 mRNA expression, and these expression levels were highly correlated (Pearson correlation coefficient r=0.79). In contrast, immunohistochemistry performed on a larger and more varied number of cases highlighted significant differences between the 2 proteins. We identified 5 non-neural, nonmelanocytic sarcoma types in which a subset of cases showed S100 protein expression: synovial sarcoma (12/79, 15%), Ewing sarcoma (3/14, 21%), rhabdomyosarcoma (4/17, 24%), chondrosarcoma (3/4, 75%), and extraskeletal myxoid chondrosarcoma (5/11, 45%). For each of these entities, we identified cases with strong and diffuse S100 staining. Of these cases, only 1 case of rhabdomyosarcoma showed focal Sox10 positivity. In 78 cases of MPNST, S100 increased the sensitivity (31/78, 40%) as compared with Sox10 (21/78, 27%), but the majority of these cases were negative for both Sox10 and S100 (44/78, 56%). Sox10 proved superior to S100 in the detection of desmoplastic melanoma (7/9, 78%) and clear-cell sarcoma (4/7, 57%). We also report for the first time Sox10 expression in 26 cases of granular cell tumor, further supporting the neural crest derivation of this tumor. Excluding MPNST, S100 and Sox10 showed similar sensitivity in tumors of neural crest origin (140/148, 95% and 137/148, 93%, respectively). In summary, Sox10 shows an increased specificity for tumors of neural crest origin compared with S100: Sox10 was positive in only 5 of 668 cases (99% specificity) in nonschwannian, nonmelanocytic tumors, whereas S100 was positive in 53 of 668 cases (91% specificity). Sox10 should be used in the place of or along with S100 in soft tissue tumor diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sox10, a Novel Transcriptional Modulator in Glial Cells
Kuhlbrodt, K., Herbarth, B., Sock, E., Hermans-Borgmeyer, I., & Wegner, M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00237.1998 · Cited by 781
Sox10: A Pan-Schwannian and Melanocytic Marker
Nonaka, D., Chiriboga, L., & Rubin, B. P. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181658c14 · Cited by 405
Herbarth, B., Pingault, V., Bondurand, N., Kuhlbrodt, K., Hermans-Borgmeyer, I., Puliti, A., Lemort, N., Goossens, M., & Wegner, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5161 · Cited by 370
Terry, J., Saito, T., Subramanian, S., Ruttan, C., Antonescu, C. R., Goldblum, J. R., Downs-Kelly, E., Corless, C. L., Rubin, B. P., van de Rijn, M., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213330.71745.39 · Cited by 351
Self-citationParatore, C., Goerich, D. E., Suter, U., Wegner, M., & Sommer, L. (2001) · Development · doi:10.1242/dev.128.20.3949 · Cited by 338
Schwann Cell–Derived Desert Hedgehog Controls the Development of Peripheral Nerve Sheaths
Parmantier, E., Lynn, B., Lawson, D., Turmaine, M., Namini, S. S., Chakrabarti, L., McMahon, A. P., Jessen, K. R., & Mirsky, R. (1999) · Neuron · doi:10.1016/s0896-6273(01)80030-1 · Cited by 334
Sorting out Sox10 functions in neural crest development
Kelsh, R. N. (2006) · BioEssays · doi:10.1002/bies.20445 · Cited by 252
Bondurand, N. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2783 · Cited by 216
Prospective Evaluation of TLE1 as a Diagnostic Immunohistochemical Marker in Synovial Sarcoma
Jagdis, A., Rubin, B. P., Tubbs, R. R., Pacheco, M., & Nielsen, T. O. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181b7ed36 · Cited by 167
Self-citationFunctional Analysis of Sox10 Mutations Found in Human Waardenburg-Hirschsprung Patients
Kuhlbrodt, K., Schmidt, C., Sock, E., Pingault, V., Bondurand, N., Goossens, M., & Wegner, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23033 · Cited by 160
Nielsen, T., Hsu, F. D., O'Connell, J., Gilks, C., Sorensen, P., Linn, S., West, R. B., Liu, C. L., Botstein, D., Brown, P. O., et al. (2003) · American Journal of Pathology · doi:10.1016/s0002-9440(10)63502-x · Cited by 153
Self-citationSubramanian, S., Thayanithy, V., West, R. B., Lee, C., Beck, A. H., Zhu, S., Downs-Kelly, E. P., Montgomery, K. D., Goldblum, J. R., Hogendoorn, P. C. W., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2633 · Cited by 126
Self-citationSOX10 immunostaining distinguishes desmoplastic melanoma from excision scar
Ramos-Herberth, F., Karamchandani, J., Kim, J., & Dadras, S. S. (2010) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2010.01568.x · Cited by 107
Self-citationImplementation of GenePattern within the Stanford Microarray Database
Hubble, J., Demeter, J., Jin, H., Mao, M., Nitzberg, M., Reddy, T. B. K., Wymore, F., Zachariah, Z. K., Sherlock, G., & Ball, C. A. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn786 · Cited by 106
Shimada, H., Newton, W. A., Soule, E. H., Qualman, S. J., Aoyama, C., & Maurer, H. M. (1988) · Human Pathology · doi:10.1016/s0046-8177(88)80495-7 · Cited by 98
Disrupted SOX10 regulation of GJC2 transcription causes Pelizaeus‐Merzbacher‐like disease
Osaka, H., Hamanoue, H., Yamamoto, R., Nezu, A., Sasaki, M., Saitsu, H., Kurosawa, K., Shimbo, H., Matsumoto, N., & Inoue, K. (2010) · Annals of Neurology · doi:10.1002/ana.22022 · Cited by 40
Pingault, V., Bondurand, N., Caignec, C. L., Tardieu, S., Lemort, N., Dubourg, O., Leguern, É., Goossens, M., & Boespflug‐Tanguy, O. (2001) · Journal of Neurology · doi:10.1007/s004150170159 · Cited by 29
Cited by
Schaefer, I.-M., Fletcher, C. D., & Hornick, J. L. (2016) · Modern Pathology · doi:10.1038/modpathol.2015.134 · Cited by 317
Miettinen, M., McCue, P. A., Sarlomo-Rikala, M., Biernat, W., Czapiewski, P., Kopczynski, J., Thompson, L. D., Lasota, J., Wang, Z., & Fetsch, J. F. (2015) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000398 · Cited by 305
Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST
Prieto-Granada, C. N., Wiesner, T., Messina, J. L., Jungbluth, A. A., Chi, P., & Antonescu, C. R. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000564 · Cited by 294
Sarcoma care in the era of precision medicine
Wallander, K., Öfverholm, I., Boye, K., Tsagkozis, P., Papakonstantinou, A., Lin, Y., & Haglund de Flon, F. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13717 · Cited by 30
Metadata
- Authors
- Karamchandani, J. R., Nielsen, T. O., van de Rijn, M., & West, R. B.
- Venue
- Applied Immunohistochemistry & Molecular Morphology
- Published
- 2012-10
- Volume
- 20
- Issue
- 5
- Pages
- 445-450
- ISSN
- 1533-4058 (ISSN-L)
- 1541-2016
- OpenAlex
- W1976572351
- Cited by
- 357
- References
- 17
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.